21 – 27 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2001
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
(
- Contribution to journal › Scientific review
- 2000
-
Mark
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
(
- Contribution to journal › Article
- 1995
-
Mark
Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
- 1991
-
Mark
A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4
(
- Contribution to journal › Article
- 1990
-
Mark
Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinoma
(
- Contribution to journal › Article
- 1985
-
Mark
Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »